On November 25, 2024 Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, reported that the company will participate in two upcoming investor conferences in December (Press release, Flare Therapeutics, NOV 25, 2024, View Source [SID1234648627]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

7th Annual Evercore ISI HealthCONx Conference: Douglas Manion, M.D., FRCP (C), Chief Executive Officer and Daphne Karydas, President and Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024 at 12:55 p.m. ET in Coral Gables, Florida.

Piper Sandler 36th Annual Healthcare Conference: Douglas Manion, M.D., FRCP (C), Chief Executive Officer, will present a company overview on Thursday, December 5, 2024 at 9:50 a.m. ET in New York, NY. Daphne Karydas, President and Chief Financial Officer will also be available for meetings with investors.